Hello Loyal G-Cap Customers,

We hope you had a great Thanksgiving! Some exciting news regarding the Galactic Cap this month. We were featured in Business Insider, a national online publication. The article highlights our revolutionary new product which is designed to vastly increase pleasure compared to traditional condoms. You can read the full article here.

The history of the condom goes back 400 years, and there hasn't been any significant improvement until now. As you may know, the Galactic Cap fits safely and securely on the the head of the penis, leaving the coronal ridge and shaft exposed for more skin to skin contact, more sexual pleasure, and ultimately more condom usage around the world.
We recently attended the National Contraceptive Meeting in Houston, an industry event that brings together academic researchers, entrepreneurs, philanthropic organizations, and the federal government to address updates in the field of contraceptive research.

We have applied for research funding through the National Institute of health (NIH), and are awaiting approval to begin our phase 1 study in 2024.
Don't Forget to Gallatio!
What can you do? We are requesting your support of our efforts to deliver a male contraceptive with more safety, reliability, and pleasure than a traditional condom. As many of you know, sales to the US market have been voluntarily suspended pending FDA approval.
 
In the meantime, customers can order the our new Gallatio. Check out our website https://www.gallatio.com/ and enter with the password: gallatio (all lowercase). The ordering process and the prices are identical to the Galactic Cap. Only the product description focus has changed to: “For Oral Pleasure”.
 
We don’t attribute any pregnancy prevention and/or STD/HIV reduction claims to the Gallatio. What you do with the product is up to you. If you have any questions, don’t hesitate to contact us.

Also, the company invites qualified investors with interest in our product to contact Charles Powell, Founder & CEO directly. We are dedicated to completing clinical research and bringing this amazing product to market.
All the best,
Charlie
 
Charles Powell
Founder & CEO
Powell Development Group, Inc.
310-880-6427